<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.14 Criteria for Certification of Qualified Maryland Biotechnology Companies. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/24.05/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/24.05/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|24|05|03|.14|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="24|05|03|.14" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/24.05.03.14"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".14 Criteria for Certification of Qualified Maryland Biotechnology Companies. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/24.05/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/24.05/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message"> </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|24" data-search-heading="">
                  <a href="/us/md/exec/comar/24" title="Title 24 DEPARTMENT OF COMMERCE">Title 24 DEPARTMENT OF COMMERCE</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|24|05" data-search-heading="">
                  <a href="/us/md/exec/comar/24.05" title="Subtitle 05 ECONOMIC DEVELOPMENT">Subtitle 05 ECONOMIC DEVELOPMENT</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|24|05|03" data-search-heading="">
                  <a href="/us/md/exec/comar/24.05.03" title="Chapter 03 Biotechnology Investment Incentive Tax Credit">Chapter 03 Biotechnology Investment Incentive Tax Credit</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|24|05|03|.14" data-search-heading="">
                  <span title=".14 Criteria for Certification of Qualified Maryland Biotechnology Companies.">.14 Criteria for Certification of Qualified Maryland Biotechnology Companies.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="24|05|03|.14">
              <div class="tuf-authenticate">
                <h1 class="h__title--small" id="/us/md/exec/comar/24.05.03.14">.14 Criteria for Certification of Qualified Maryland Biotechnology Companies.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> The Department shall assess the merits of a company’s application for certification as a qualified Maryland Biotechnology company according to:</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> The criteria set forth in this chapter;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> The definition of biotechnology stated in <a class="internal-link " href="/us/md/exec/comar/24.05.03.14#C" title="">§C of this regulation</a>; and</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> Other metrics and measures that the Secretary may adopt for uniform application under this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> The Department shall apply a facts and circumstances analysis on a case by case basis to determine whether a company meets the criteria of this chapter.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Biotechnology.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> Definition.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(a)">(a)</span> “Biotechnology” means innovative and proprietary technology that comprises, interacts with, or analyzes biological material including biomolecules (DNA, RNA, or protein), cells, tissues, or organs and includes the application of scientific and technical advances to develop commercial products.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(1)(b)">(b)</span> “Biotechnology” includes the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(i)">(i)</span> DNA/RNA: Genomics, pharmacogenomics, gene probes, genetic engineering, DNA/RNA sequencing/synthesis/amplification, gene expression profiling, and use of antisense technology;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(ii)">(ii)</span> Proteins and other biomolecules including sugars, lipids, vitamins and metabolics; sequencing, synthesis, or engineering of molecules; improved delivery methods for drugs; isolation; purification, and identification of cell receptors;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(iii)">(iii)</span> Cell and tissue culture and engineering: Cell/tissue culture, tissue engineering (including tissue scaffolds and biomedical engineering), cellular fusion, vaccine/immune stimulants, embryo manipulation;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(iv)">(iv)</span> Process biotechnology techniques: fermentation using bioreactors, bioprocessing, bioleaching, biopulping, biobleaching, biodesulphurisation, bioremediation, biofiltration, and phytoremediation;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(v)">(v)</span> Gene and RNA vectors: gene therapy, viral vectors;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(vi)">(vi)</span> Bioinformatics: construction of databases on genomes, protein sequences; modeling complex biological processes, including systems biology and mechanism of actions of drugs; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(1)(b)(vii)">(vii)</span> Nanobiotechnology: Applies the tools and processes of nano/microfabrication to build devices for studying biosystems and applications in drug delivery, diagnostics, and other applications.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> Single Definition.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(a)">(a)</span> Section C(1)(a) of this regulation is referred to in this chapter as “the single definition”. The single definition is deliberately broad, general, and provisional. The single definition applies to the word “biotechnology” as used in the term “biotechnology company” stated in <a class="internal-link " href="https://mgaleg.maryland.gov/mgawebsite/laws/StatuteText?article=gtg&amp;section=10-725" title="">Tax-General Article, §10-725(a)(2), Annotated Code of Maryland</a>.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(b)">(b)</span> The single definition connotes the manipulation of living organisms or their components to produce useful commercial products and the innovative and proprietary technologies of biological science used in this manipulation.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(3)">(3)</span> List–Based Definition. The list-based definition is based on the list of biotechnology techniques in <a class="internal-link " href="/us/md/exec/comar/24.05.03.14#C(1)(b)" title="">§C(1)(b) of this regulation</a> and will function for the Department as an interpretative guideline to the single definition. The list is indicative rather than exhaustive and is expected to change over time as biotechnology techniques evolve.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(4)">(4)</span> The single definition covers all modern biotechnology but also many traditional or borderline activities. In application by the Department under this chapter, the single definition will always be accompanied by the list-based definition stated in <a class="internal-link " href="/us/md/exec/comar/24.05.03.14#C(1)(b)" title="">§C(1)(b) of this regulation</a> when the Department applies the single definition to particular facts and circumstances for the purposes of this chapter. The single definition and the list definition will be applied in conjunction under this chapter to take account of and to consider biotechnology techniques that fit the single definition but may not fit the list–based definition, with a view to constantly updating the list-based definition.</p>
                <p class="text-indent-1 "><span class="level-num" id="D">D.</span> Criteria for a Biotechnology Company.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(1)">(1)</span> A biotechnology company is a company primarily dedicated to turning the biological sciences into a commercial product and to commercialize the results. The Department shall apply the single definition and the list definition to determine whether a company’s activities or products constitute biotechnology for the purposes of the Act and this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(2)">(2)</span> The scientific biotechnological basis of the company’s activities and plans is defining, but not conclusive.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(3)">(3)</span> The company shall demonstrate that the investment it will attract by reason of the tax credit available under the Act and this chapter will be likely to:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(a)">(a)</span> Materially advance and support the business viability of the company; and</p>
                <p class="text-indent-3 "><span class="level-num" id="D(3)(b)">(b)</span> Result in the production of a biotechnology product that will contribute to economic development and employment growth in the State.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(4)">(4)</span> Stage of Development. The company shall:</p>
                <p class="text-indent-3 "><span class="level-num" id="D(4)(a)">(a)</span> Have begun active activities and operations and fairly be characterized as actively engaged in a biotechnology business;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(4)(b)">(b)</span> Be fully legally organized under the laws of the jurisdiction in which it was organized;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(4)(c)">(c)</span> Have competent management;</p>
                <p class="text-indent-3 "><span class="level-num" id="D(4)(d)">(d)</span> Own or have immediately available and useable rights in biotechnology-related intellectual property; and</p>
                <p class="text-indent-3 "><span class="level-num" id="D(4)(e)">(e)</span> Be actively engaged in research, development, or production of a commercially oriented, innovative, and patent protectable biotechnology product.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(5)">(5)</span> Eligibility: “Active Business”.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(5)(a)">(a)</span> Except as provided in §C(5)(b) of this regulation, a company is eligible for certification as a qualified Maryland biotechnology company if it has been in active business not longer than 10 years.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(5)(b)">(b)</span> A company that has been in active business for up to 12 years may be eligible for certification as a QMBC if the Department determines that the company requires additional time to complete the process of regulatory approval of a biotechnology product.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(5)(c)">(c)</span> “Active business” means that the Department can reasonably determine and establish the nature of the Company’s commercial biotechnology research, development or production operations. The mere legal organization, appointment or election of officers or managers, initial capitalization, and establishment of business offices of a company, alone or in combination, are not sufficient to establish that the company is engaged in active business for the purposes of this chapter and the Act.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(5)(d)">(d)</span> The Department shall apply a facts and circumstances analysis on a case by case basis to determine whether a company has been engaged in active business and for what period of time.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(6)">(6)</span> Commercialization of an Identifiable Biotechnology Product.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(6)(a)">(a)</span> The company shall have a developed, focused plan for:</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(a)(i)">(i)</span> Research and development of an identifiable biotechnology product; and</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(a)(ii)">(ii)</span> The company’s growth.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(6)(b)">(b)</span> A biotechnology product will generally be:</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(b)(i)">(i)</span> Used for human health, as in a therapeutic or diagnostic setting (for example, to treat, detect, or prevent diseases or to improve treatment outcomes);</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(b)(ii)">(ii)</span> Used on domesticated or farm animals, as in a therapeutic or diagnostic setting (for example, to improve animal health); or plants (for example to increase agricultural production); or</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(b)(iii)">(iii)</span> An application originally derived from use of a living organism, as in production of alternative energy (e.g., biofuels) or engineering or chemistry derived from nature to improve properties of products (for example, re-engineering of attachment molecules used by mollusks for the next SuperGlue®).</p>
                <p class="text-indent-3 "><span class="level-num" id="D(6)(c)">(c)</span> In general, companies will not be certified that provide a service (e.g., analytical services or consulting services, etc.) or develop software, or develop or manufacture products or technology that do not involve use or application of biotechnology.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(6)(d)">(d)</span> A device may constitute eligible biotechnology if:</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(d)(i)">(i)</span> It delivers a direct therapeutic effect through biological interaction; or</p>
                <p class="text-indent-4 "><span class="level-num" id="D(6)(d)(ii)">(ii)</span> It performs a diagnosis through analyzing biological material.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(7)">(7)</span> Innovative Biotechnology Projects and Products. The company shall provide evidence with its application that its existing or proposed biotechnology product is innovative and has the potential for commercial sale. The company must generally own the intellectual property or have exclusive rights to the use of the intellectual property.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(8)">(8)</span> Maryland Location.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(8)(a)">(a)</span> The company shall demonstrate that its headquarters and the base of its biotechnology operations are entirely located in the State.</p>
                <p class="text-indent-3 "><span class="level-num" id="D(8)(b)">(b)</span> The company shall provide with its application evidence that it will maintain its headquarters, the base of its biotechnology operations, and the sites, buildings, and facilities in which its headquarters and biotechnology operations are or will be conducted, in the State for a period of not less than 48 months after the date on which its application for certification as a qualified Maryland biotechnology company is submitted to the Department.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/24.05.03.13" aria-label=".13 Procedures for Certification of Qualified Maryland Biotechnology Companies.">
                <div class="h__ui">Previous</div>
                <span>.13 Procedures for Certification of Qualified Maryland Biotechnology Companies.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/24.05.03.15" aria-label=".15 Ownership Attribution.">
                <div class="h__ui">Next</div>
                <span>.15 Ownership Attribution.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">

<p>
      Please do not scrape. Instead, bulk download the CC-BY-SA <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
